BackThe Hydration Pharmaceuticals Company Limited Overview
The Hydration Pharmaceuticals Company Limited

The Hydration Pharmaceuticals Company Limited Return on Equity

Latest ROE for The Hydration Pharmaceuticals Company Limited: 282.93% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

282.93%

Return on Equity

282.93%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

The Hydration Pharmaceuticals Company Limited (HPC.AX) FAQ

As of the most recent data, HPC.AX shows a ROE of 282.93%. That is above the sector sector average of 11.85%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.85%. The Hydration Pharmaceuticals Company Limited is at 282.93%, which is higher that average. That is roughly 2287.2% above the sector mean. Use the comparison chart on this page to see how HPC.AX stacks up against individual peers as well.

Check the historical chart to see whether HPC.AX's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare The Hydration Pharmaceuticals Company Limited with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has The Hydration Pharmaceuticals Company Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 282.93%) with ownership activity and broader fundamentals.